Wogonin Ameliorates Renal Inflammation and Fibrosis by Inhibiting NF-κB and TGF-β1/Smad3 Signaling Pathways in Diabetic Nephropathy.
Zhi-Chao ZhengWei ZhuLei LeiXue-Qi LiuYong-Gui WuPublished in: Drug design, development and therapy (2020)
Wogonin may ameliorate renal inflammation and fibrosis in diabetic nephropathy by inhibiting the NF-κB and TGF-β1/Smad3 signaling pathways.